Daniel Lochner
CIK 1791187 · Chief Financial Officer · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.77M
Companies
2
Total Filings
23
Lifetime Open-Market Net
$480.4K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TECX | Chief Financial Officer | 58,544 | $30.28 | $1.77M | $379.6K | 7 | 2026-06-12 |
| Oyster Point Pharma, Inc. (OYST) Delisted | Chief Financial Officer | 20,236 | $11.17 | $226.0K | $100.8K | 15 | 2023-01-04 |
Recent Filings · Page 3 of 3
23 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-08-12 | Oyster Point Pharma, Inc. (OYST) Delisted | Exer (M) | +4,000 | $46.0K | EDGAR |
| 2020-02-05 | Oyster Point Pharma, Inc. (OYST) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-11-05 | Oyster Point Pharma, Inc. (OYST) Delisted | Buy (P) | +6,300 | $100.8K | EDGAR |
Showing 21–23 of 23
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.